STOCKHOLM--(BUSINESS WIRE)--Regulatory News: First quarter January-March 2015 · Order intake was SEK 471 (287) million · Order backlog was SEK 869 (193) million · Net sales were SEK 304 (242) million · EBIT was SEK 26 (3) million · Earnings per share were SEK 0.19 (0.01) Outlook The Board’s assessment is that sales in 2015 will be in the span SEK 1,650-1,750 million. Stable start to the year “This year opened well for Mycronic (STO:MYCR), even without any mask writer deliveries during the first